4//SEC Filing
Landsberg Moshe 4
Accession 0001178913-09-001608
CIK 0001451980other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 4:49 PM ET
Size
7.1 KB
Accession
0001178913-09-001608
Insider Transaction Report
Form 4
BIOCANCELL THERAPEUTICS INC.BICL.TA
Landsberg Moshe
Vice President of Technology
Transactions
- Purchase
Common Stock, par value $0.01
2009-07-06+7,143→ 8,143 total - Award
Employee Options
2008-12-03+211,250→ 260,000 totalExp: 2018-12-03→ Common Stock, par value $0.01 (211,250 underlying)
Footnotes (3)
- [F1]The average purchase price was 2.80 NIS per share.
- [F2]The exercise price is 1.27 NIS per share.
- [F3]16,250 options shall be exercisable at the end of each calendar quarter, until September 30, 2012
Documents
Issuer
BIOCANCELL THERAPEUTICS INC.
CIK 0001451980
Entity typeother
Related Parties
1- filerCIK 0001466925
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 4:49 PM ET
- Size
- 7.1 KB